Medbroker ApS: Financial statements 2024
CVR: 31892236
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Medbroker ApS (CVR 31892236) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -144,251 and a net result of DKK -406,760 compared with DKK -404,955 the year before. Equity in the 2024 report amounted to DKK 113,652. The solvency ratio was 37.1%.
- Gross Profit
- DKK -144,251
- Profit/Loss
- DKK -406,760
- Equity
- DKK 113,652
- Total Assets
- DKK 306,558
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -144 t. | -407 t. | 114 t. | 0 |
| 2023 | - | -66 t. | -405 t. | 520 t. | 1 |
| 2022 | - | -57 t. | -335 t. | 925 t. | 1 |
| 2021 | - | 130 t. | -343 t. | 1.3 mio. | 1 |
| 2020 | - | 646 t. | -182 t. | 1.6 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Medbroker ApS has published its annual report for 2023. Gross profit came to DKK -65,721, and the net result was DKK -404,955.
As of May 29, 2024, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of Medbroker ApS.
About Medbroker ApS
Medbroker ApS is a Danish company of the type Anpartsselskab based in Gadstrup, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ORIGO BIOTECH ApS. The management consists of Henrik Carlheim Dørge. The board consists of Henrik Carlheim Dørge (chair). The company is owned by MEDBROKER INVEST ApS. The company has 3 employees (2023). In 2025, the company reported a gross profit of DKK -6,226 and a net result of DKK -78,938 compared with DKK -406,760 the year before. Equity in the 2025 report amounted to DKK 34,714.